Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

NLX-101 (F15599) is under development for the treatment of Rett syndrome and depression. The drug candidate is administered by oral route. The drug candidate is a new chemical entity (NCE). The drug ...

Mavoglurant is under development for the treatment of cocaine use disorder, alcohol use disorder and for language learning in young children with fragile X syndrome (FXS). The drug candidate is ...

NeuroQuiet is an advanced auditory support supplement that takes hearing experience to the next level. It strategically ...

Objective: To review the use of number needed to treat (NNT) and/or number needed to harm (NNH) values to determine their relevance in helping clinicians evaluate cost-effectiveness analyses (CEAs).

A "Class I" recall means "there is a reasonable probability that the use of or exposure to a violative ... A dog is given a treat on a walk. The Hollywood Feed dog treats were recalled on November ...

1 With the approval of the allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC) therapy, remestemcel-L-rknd is the first FDA-approved MSC therapy. 1 "Today’s decision marks an ...

Ms Wells is now on medication for the rest of her life and the treatment comes with side effects ... The herb has been used for centuries in traditional Indian and Chinese medicine and is promoted ...

However, most of the drug is trapped in the liver, so it cannot damage other organs in your body. Chemoembolization may be used to treat patients with other cancers that have spread to the liver. The ...

It is an oral solution to treat seizures. The company said the solution is bioequivalent and therapeutically equivalent to the reference listed drug, Vimpat Oral Solution, 10 mg/ml of UCB, Inc. It is ...

Premier Andrew Furey says under the new Churchill Falls agreement, N.L. will receive $1 billion a ... Furey said he has his eye on several ways to use the initial annual payments of $1 billion ...

Evidence is mounting that new therapies already used to treat gut diseases, type 2 diabetes, and obesity may help people with alcohol use disorder (AUD). Glucagon-like peptide 1 (GLP-1 ...